Pharmacokinetics, Safety, and Tolerability of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Diskus® Administered in Healthy Subjects: an Open-Label, Randomized, Three-Period Crossover, Single-Dose Study

Trial Profile

Pharmacokinetics, Safety, and Tolerability of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Diskus® Administered in Healthy Subjects: an Open-Label, Randomized, Three-Period Crossover, Single-Dose Study

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2015

At a glance

  • Drugs Fluticasone propionate (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 19 May 2015 Status changed from not stated to completed.
    • 30 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top